These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35942120)

  • 21. Ultrasonically controlled particle size distribution of explosives: a safe method.
    Patil MN; Gore GM; Pandit AB
    Ultrason Sonochem; 2008 Mar; 15(3):177-87. PubMed ID: 17532248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering of acetaminophen particle attributes using a wet milling crystallisation platform.
    Ahmed B; Brown CJ; McGlone T; Bowering DL; Sefcik J; Florence AJ
    Int J Pharm; 2019 Jan; 554():201-211. PubMed ID: 30391338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development in modeling submicron particle formation in two phases flow of solvent-supercritical antisolvent emulsion.
    Dukhin SS; Shen Y; Dave R; Pfeffer R
    Adv Colloid Interface Sci; 2007 Oct; 134-135():72-88. PubMed ID: 17568550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of drug processability in a connected continuous crystallizer system using formulation additive.
    Tacsi K; Stoffán G; Galata DL; Pusztai É; Gyürkés M; Nagy B; Szilágyi B; Nagy ZK; Marosi G; Pataki H
    Int J Pharm; 2023 Mar; 635():122725. PubMed ID: 36804519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of Operation Strategy Based on Solution pH for Improving the Crystal Quality Formed during Reactive Crystallization of l-Aspartic Acid.
    Amari S; Sugawara C; Kudo S; Takiyama H
    ACS Omega; 2022 Jan; 7(3):2989-2995. PubMed ID: 35097291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation performance and agglomeration behavior analysis of solution crystallization in food engineering.
    Jia S; Wan X; Yao T; Guo S; Gao Z; Wang J; Gong J
    Food Chem; 2023 Sep; 419():136051. PubMed ID: 37030210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling Diffusive Mixing in Antisolvent Crystallization.
    Miller R; Sefcik J; Lue L
    Cryst Growth Des; 2022 Apr; 22(4):2192-2207. PubMed ID: 35431661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleation of crystals from solution: classical and two-step models.
    Erdemir D; Lee AY; Myerson AS
    Acc Chem Res; 2009 May; 42(5):621-9. PubMed ID: 19402623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focused beam reflectance measurement as a tool for in situ monitoring of the lactose crystallization process.
    Pandalaneni K; Amamcharla JK
    J Dairy Sci; 2016 Jul; 99(7):5244-5253. PubMed ID: 27132102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the Evolution of Crystal Size and Shape during Temperature Cycling and in the Presence of a Polymeric Additive Using Combined Process Analytical Technologies.
    Simone E; Klapwijk AR; Wilson CC; Nagy ZK
    Cryst Growth Des; 2017 Apr; 17(4):1695-1706. PubMed ID: 28867966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of direct crystallization for racemic compound propranolol hydrochloride.
    Wang X; Lu J; Ching CB
    J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling.
    Medarević D; Djuriš J; Ibrić S; Mitrić M; Kachrimanis K
    Int J Pharm; 2018 Apr; 540(1-2):150-161. PubMed ID: 29438724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction.
    Tona RM; McDonald TAO; Akhavein N; Larkin JD; Lai D
    Lab Chip; 2019 Jun; 19(12):2127-2137. PubMed ID: 31114833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode.
    Nguyen TN; Kim KJ
    Int J Pharm; 2008 Nov; 364(1):1-8. PubMed ID: 18582549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of initial concentration and seeding procedure on crystallisation of orthorhombic paracetamol from ethanolic solution.
    Al-Zoubi N; Malamataris S
    Int J Pharm; 2003 Jul; 260(1):123-35. PubMed ID: 12818817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystallization of a polymorphic hydrate system.
    Tian F; Qu H; Louhi-Kultanen M; Rantanen J
    J Pharm Sci; 2010 Feb; 99(2):753-63. PubMed ID: 19569226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On Solute Recovery and Productivity in Chiral Resolution through Solid-State Deracemization by Temperature Cycling.
    Hosseinalipour MS; Deck LT; Mazzotti M
    Cryst Growth Des; 2024 May; 24(9):3925-3932. PubMed ID: 38708369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.